单位:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, China.[2]Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.[3]Department of Nasopharyngeal Carcinoma, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.[4]Department of Medical Imaging, Sun Yat-sen University Cancer Centre, Guangzhou, China.[5]Department of Neurosurgery, Third Affiliated Hospital of Southern Medical University, Guangzhou, China.[6]Department of Minimally Invasive Interventional Radiology, Sun Yat-sen University Cancer Centre, Guangzhou, China.[7]Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.肿瘤科华中科技大学同济医学院附属同济医院[8]Institute of Molecular Medicine and Experimental Immunology, University Clinic of Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
Enterprise joint
fund of Guangdong Provincial Foundation for Basic and
Applied Basic Research (2021A1515220021), The National
Natural Science Foundation of China (Grant/Award Number:
81902638), Program of Sun Yat‐Sen University for Clinical
Research 5010 Program (No.2015011), Wu Jieping Medical
Foundation (Grant/Award Number: 320.6750.2021‐01‐38).
第一作者单位:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, China.[2]Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.[3]Department of Nasopharyngeal Carcinoma, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, Guangzhou, China.[2]Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.[3]Department of Nasopharyngeal Carcinoma, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.[*1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou 510060, People's Republic of China.
推荐引用方式(GB/T 7714):
Liu Yong-Long,Wen Kai,Zhang Wei-Jing,et al.Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients[J].OTOLARYNGOLOGY-HEAD AND NECK SURGERY.2024,170(2):447-456.doi:10.1002/ohn.615.
APA:
Liu Yong-Long,Wen Kai,Zhang Wei-Jing,Ouyang Yan-Feng,Chen Jin-Hua...&Li Jian.(2024).Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients.OTOLARYNGOLOGY-HEAD AND NECK SURGERY,170,(2)
MLA:
Liu Yong-Long,et al."Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients".OTOLARYNGOLOGY-HEAD AND NECK SURGERY 170..2(2024):447-456